SciSparc
SPRC
2 hedge funds and large institutions have $88.2K invested in SciSparc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
1.49% less ownership
Funds ownership: 5.15% → 3.66% (-1.5%)
32% less capital invested
Capital invested by funds: $129K → $88.2K (-$41.3K)
50% less funds holding
Funds holding: 4 → 2 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$18.7K |
| 2 |
SG
StoneX Group
New York
|
-$11.5K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$10K |
SPRC Hedge Fund Activity: Q4 2022 in Review
2 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in SciSparc (SPRC) for Q4 2022, worth a combined $88.2K — down 32% from $129K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SPRC and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $18.7K.
- 2 institutional investors held SciSparc (SPRC) as of Q4 2022, down from 4 in Q3 2022.
- Funds reported $88.2K of SciSparc stock for Q4 2022, down 32% quarter-over-quarter.
- 0 funds opened new SciSparc positions in Q4 2022 and 2 closed out, a net change of -2 holders.
- The largest SciSparc seller in Q4 2022 was UBS Group, an estimated $18.7K sold.
Based on aggregated 13F filings for Q4 2022.